ALL | PAP TEST RESULTS | Â | Â | |||||
---|---|---|---|---|---|---|---|---|
 | Negative | ASC-US | L-SIL+ |  |  | |||
 | 3151 | 117 | 90 |  |  | |||
HPV INFECTION | N | % | N | % | N | % | PAR ASC-US+ (95% CI) | PAR L-SIL+ (95% CI) |
HPV negative | 2844 | 90.3 | 77 | 65.8 | 25 | 27.8 | Â | Â |
16-18 alone | 43 | 1.4 | 8 | 6.8 | 17 | 18.9 | 11.2 (6.6-15.7) | 18.4 (9.8-26.1) |
16-18 & other HR+ | 28 | 0.9 | 1 | 0.9 | 7 | 7.8 | 3.3 (0.5-6.0) | 7.4 (1.7-12.8) |
16-18 & LR+ | 3 | 0.1 | 0 | 0.0 | 2 | 2.2 | 0.9 (0.0-2.2) | 2.2 (0.0-5.2) |
6-11 alone | 17 | 0.5 | 1 | 0.9 | 0 | 0.0 | 0.2 (0.0-1.1) | Â |
6-11 & HR+ (excluded 16-18) | 2 | 0.1 | 1 | 0.9 | 2 | 2.2 | 1.4 (0.2-3.0) | 2.2 (0.0-5.2) |
6-11 & other LR+ | 1 | 0.0 | 1 | 0.9 | 0 | 0.0 | 0.5 (0.5-1.4) | Â |
other HR+ only | 142 | 4.5 | 22 | 18.8 | 32 | 35.6 | 23.4 (16.5-29.6) | 33.9 (22.9-43.4) |
other LR+ only | 63 | 2.0 | 5 | 4.3 | 3 | 3.3 | 2.7 (0.0-5.5) | 2.7 (0.0-6.4) |
other HR+ & LR+ | 8 | 0.3 | 1 | 0.9 | 2 | 2.2 | 1.3 (0.0-2.9) | 2.1 (0.0-5.1) |
< = 35 years | Â | Â | Â | Â | Â | Â | Â | Â |
 | PAP TEST RESULTS |  |  | |||||
 | Negative | ASC-US | L-SIL+ |  |  | |||
 | 771 | 42 | 41 |  |  | |||
HPV INFECTION | N | % | N | % | N | % | PAR ASC-US+ (95% CI) | PAR L-SIL+ (95% CI) |
HPV negative | 649 | 84.2 | 22 | 52.4 | 9 | 22.0 | Â | Â |
16-18 alone | 19 | 2.5 | 4 | 9.5 | 8 | 19.5 | 13.4 (5.3-20.8) | 18.8 (5.6-30.2) |
16-18 & other HR+ | 17 | 2.2 | 1 | 2.4 | 4 | 9.8 | 5.1 (0.0-10.2) | 9.1 (0.0-17.9) |
16-18 & LR+ | 1 | 0.1 | 0 | 0.0 | 1 | 2.4 | 1.2 (0.0-3.5) | 2.4 (0.0-7.0) |
6-11 alone | 8 | 1.0 | 1 | 2.4 | 0 | 0.0 | 0.7 (0.0-3.1) | Â |
6-11 & HR+(exclued 16-18) | 2 | 0.3 | 0 | 0.0 | 2 | 4.9 | 2.3 (0.0-5.6) | 4.8 (0.0-11.2) |
6-11 & other LR+ | 1 | 0.1 | 1 | 2.4 | 0 | 0.0 | 1.2 (0.0-3.5) | Â |
other HR+ only | 52 | 6.7 | 9 | 21.4 | 15 | 36.6 | 26.0 (14.7-35.8) | 34.8 (17.5-48.4) |
other LR+ only | 19 | 2.5 | 3 | 7.1 | 0 | 0.0 | 2.5 (0.0-6.7) | Â |
other HR+ & LR+ | 3 | 0.4 | 1 | 2.4 | 2 | 4.9 | 3.5 (0.0-7.4) | 4.8 (0.0-11.1) |